Device Trial Radar · NCT07695558
Post Market Study of the Flexagon Only System and Flexagon Plus OTOLoc for Creation of Side-to-Side Duodeno-Ileal Diversion & Flexagon Plus OTOLoc Self Forming Magnet (SFM) System for Creation of Side-to-Side Jejunum-Jejunum and Ileal-Ileal Anastomoses
Last checked: Nov 19, 2026Latest source record: Nov 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
70
Planned (sponsor's estimate)
Start
Oct 27, 2026
Primary completion
Mar 2028
Study completion Jun 2028
Sponsor
- Lead sponsor
- GI Windows, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Jul 10, 2026
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Non randomized
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 22 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The objective of this study is to confirm the safety and effectiveness of the Flexagon \& Flexagon Plus OTOLoc systems when used to create respective side-to-side anastomosis in participants undergoing laparoscopic / endoscopic small bowel surgery.
Conditions
- Small Bowel Anastomosis
Interventions
Small Bowel AnastomosisDevice
Small Bowel Anastomosis
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants with Successful Anastomosis Creation without the Need for ReoperationTime frame: 30 Days
Locations
4 sites in 1 country. Site status is shown where the registry gives one.
Orlando Health Hospital
Orlando, Florida · Recruiting
LSU Health
New Orleans, Louisiana · Recruiting
New York University
New York, New York · Not yet recruiting
1 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.